1. BARICIVID-19 study: MultiCentre, randomised, Phase IIa clinical trial evaluating efficacy and tolerability of Baricitinib as add-on treatment of patients with COVID-19 compared to standard therapy;Sperimentazioni cliniche,2020
2. Studio randomizzato multicentrico in aperto sull’efficacia della somministrazione precoce del Tocilizumab in pazienti affetti da polmonite da COVID-19,2020
3. Remdesivir for the treatment of Covid-19 - preliminary report;Beigel;N. Engl. J. Med.,2020
4. Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study;Cantini;J. Infect.,2020